The New Nation - Internet Edition

BUSINESS REPORT

Square Pharmaceuticals Ltd., the market leader of the Bangladesh Pharmaceutical Industry and the first Bangladeshi pharmaceutical company to attain the UK MHRA certification has very recently started exporting its world-class pharmaceutical products to Hong Kong. Hong Kong, a Special Administrative Region of China, enjoying first world living conditions with GDP Per Capita USD 42.000, has a pharmaceutical market worth around USD 715 million.

Square Pharma has already registered 05 products in Hong Kong and has exported its pharmaceutical consignment to Hong Kong in July 2008. SQUARE has more than 20 products in queue in the office of the registration approval authority of the Department of Health, Hong Kong.

Hong Kong IS a moderately regulated market with strict enforcement of the International Patent Regime. So, SQUARE's products had to undergo the rigor and complexity of its highly meticulous regulatory screening system before attaining registration approval.

With the inclusion of another strategically important market in its export distribution like Hong Kong, SQUARE continues to maintain its stride for adding more premium export markets in its overall global international market presence.